Prosecution Insights
Last updated: May 29, 2026

The University of Birmingham

10 pending office actions • 9 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
9
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (30%)
3
Easy (30%)
4
Unknown (40%)

Rejection Statute Mix

BucketCases
§103 only3 (30%)
§112 only3 (30%)
No statute on record4 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
90% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
10% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FAN, LYNN Y 2 46.6% +49.1%
DO, ANDREW V 1 84.7% +11.4%
DARBY, BRENDON CHARLES 1 50.0% +16.6%
LEE, HOI YAN NMN 1 43.1% +77.9%
PAGANO, ALEXANDER R 1 78.8% +11.5%
SAMSELL, RILLA MARIE 1 71.4% +0.0%
SHIAO, YIH-HORNG 1 72.6% +75.6%
SHIN, DANA H 1 27.2% +27.6%
ROSEBACH, CHRISTINA H.W. 1 58.9% -35.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18491841 High Fidelity Robust Atom Optics DO, ANDREW V 43d overdue

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17940988 BIOMARKERS OF TRAUMATIC BRAIN INJURY SHIN, DANA H 111d overdue

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17940988 BIOMARKERS OF TRAUMATIC BRAIN INJURY SHIN, DANA H 111d overdue
18491841 High Fidelity Robust Atom Optics DO, ANDREW V 43d overdue
18009485 FLUID GEL COMPOSITIONS FAN, LYNN Y 11d overdue
18009144 FLUID GEL COMPOSITIONS FAN, LYNN Y 11d overdue
18009566 POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS SHIAO, YIH-HORNG 10d overdue
18033160 SPRAYABLE ANTIVIRAL FORMULATION LEE, HOI YAN NMN 8d
18250136 BATTERY RECYCLING DARBY, BRENDON CHARLES 22d
18028238 SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER PAGANO, ALEXANDER R 22d

Top Art Units

Art UnitApps
1759 2
2852 1
1749 1
1693 1
1692 1
1624 1
1691 1
1635 1
1766 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18491841 High Fidelity Robust Atom Optics DO, ANDREW V 2852 §112 Non-Final OA 43d overdue Pending Oct 23, 2023
18250136 BATTERY RECYCLING DARBY, BRENDON CHARLES 1749 §103 Non-Final OA 22d Pending Apr 21, 2023
18033160 SPRAYABLE ANTIVIRAL FORMULATION LEE, HOI YAN NMN 1693 Other Non-Final OA 8d Pending Apr 21, 2023
18028238 SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER PAGANO, ALEXANDER R 1692 §112 Non-Final OA 22d Pending Mar 24, 2023
18012561 MMP-9 AND MMP-12 INHIBITION FOR TREATING SPINAL CORD INJURY OR RELATED INJURY TO NEUROLOGICAL TISSUE SAMSELL, RILLA MARIE 1624 §103 Final Rejection 8d overdue Pending Dec 22, 2022
18009566 POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS SHIAO, YIH-HORNG 1691 Other Non-Final OA 10d overdue Pending Dec 09, 2022
18009485 FLUID GEL COMPOSITIONS FAN, LYNN Y 1759 Other Non-Final OA 11d overdue Pending Dec 09, 2022
18009144 FLUID GEL COMPOSITIONS FAN, LYNN Y 1759 Other Non-Final OA 11d overdue Pending Dec 08, 2022
17940988 BIOMARKERS OF TRAUMATIC BRAIN INJURY SHIN, DANA H 1635 §112 Non-Final OA 111d overdue Pending Sep 08, 2022
17277019 Functionalized Surface ROSEBACH, CHRISTINA H.W. 1766 §103 Non-Final OA 153d overdue Pending Mar 17, 2021

Managing The University of Birmingham's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month